Immatics is a biotechnology company focused on transforming cancer treatment through precision targeting of the PRAME antigen, which is present in over 50 types of cancer. We lead the market with a comprehensive clinical pipeline that includes innovative TCR T-cell therapies and TCR bispecifics, setting the standard for effective cancer therapies.
No jobs found. Subscribe below to get notified when we find something for you.
Searching